Chronic Low Back Pain Clinical Trial
Official title:
Effectiveness of the Functional Exercises in Young Adults Chronic Low Back Pain: a Randomized Controlled Trial
Non-specific low back pain is a common condition. Exercise is effective treatment for chronic
low back pain. We hypothesized the functional exercise group will present pain reduction and
functional improvement.
The purpose of this study is investigated the effectiveness of an functional exercise program
for people with nonspecific chronic low back pain. Patients will be randomly divided into 2
groups: control group (minimal intervention - mini back school and analgesic) and group will
receive a functional exercise protocol associated with minimal intervention.
Status | Recruiting |
Enrollment | 84 |
Est. completion date | November 10, 2018 |
Est. primary completion date | May 10, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Aged between 18 and 50 years - Low back pain for more than 3 months - Low back pain with numeric pain scale between 3 - 8 cm - Understand Portuguese well enough to be able to fill in the questionnaires Exclusion Criteria: - Inflammatory/rheumatological diseases, tumor, infection or vertebral fracture; - Main pain as leg pain (eg: nerve root compression or herniated disc with radicular pain / radiculopathy, lateral and central stenosis) - Less than 6 months after lumbar spine, lower limb or abdomen surgery - Previous spinal surgery; - Previous spinal infiltration for pain relief in the last 3 months; - Several scoliosis; - Litigation; - Pregnancy; - Fibromyalgia; - People who had changed physical activity or undergone physical therapy in the previous 3 months; - Presence of any contraindication to exercise; - Planned travel in the next 12 weeks; - Geographic inaccessibility. |
Country | Name | City | State |
---|---|---|---|
Brazil | Emilia Moreira | Sao Paulo |
Lead Sponsor | Collaborator |
---|---|
Federal University of São Paulo |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Low back of pain intensity measured with Numeric Pain Rating Scale | It will be measured by the Brazilian version of the Numeric Pain Rating Scale (NPRS) 11 points. The NPRS goes from 0 to 10, where 0 is "no pain" and 10 is "the worst pain imaginable." Participants will be asked to answer about their pain levels based on the last seven days. Change in pain score or an improvement of 2 levels or more is accepted as clinically relevant. | Baseline, 6, 12 and 24 weeks | |
Secondary | Disability associated to low back pain measured with Oswestry Disability Index | Change in Oswestry Disability Index score | Baseline, 6, 12 and 24 weeks | |
Secondary | Disability associated to low back pain measured with Roland Morris Disability | Change in Roland Morris Disability score | Baseline, 6, 12 and 24 weeks | |
Secondary | Fear of movement measured with Fear-Avoidance Beliefs Questionnaire | Change in Fear-Avoidance Beliefs Questionnaire score | Baseline, 6, 12 and 24 weeks | |
Secondary | Quality of life measured with Short form-36 questionnaire | Change in Short form-36 questionnaire score | Baseline, 6, 12 and 24 weeks | |
Secondary | Function measured with the 6-minute walk test | Change in 6-minute walk test | Baseline, 6, 12 and 24 weeks | |
Secondary | Function measured with the timed to up and go test | Change in timed to up and go test | Baseline, 6, 12 and 24 weeks | |
Secondary | Patient's global impression of recovery measured with a likert scale | It will be evaluated based on the global perceived effect by the Likert Scale Score. The Likert scale, used to evaluate the patient's global perceived effect with treatment. The patients answered the question 'After starting the treatment, how do you think your low back is?' with one of the following statements: much worse, a little worse, unchanged, a little better, much better. | 6, 12 and 24 weeks after baseline | |
Secondary | Analgesic consumption | Change in analgesic consumption | 6, 12 and 24 weeks after baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |